Abstract:A biological impact of the fused heterocyclic rings as anti-enzymatic agents was explored through experimental, theoretical and computational studies. The targeted hybrids of 1,2,4-triazole ( 8a–q ) were synthesized through multistep protocol. Initially, the carboxylate 3 was synthesized through stirring of 4-chlorobenzenesulfonyl chloride ( 1 ) and 4-(ethoxycarbonyl)piperidine ( 2 ) at room temperature. Carboxylate was converted into carbohydrazide 4 , which was refluxed with phenyl isothiocyanate and KOH to synthesize 1,2,4-triazole ( 6 ) through the formation of an intermediate hydrazinecarbothioamide (5) . A series of alkyl/aralkyl halides ( 7a–q ) were stirred at room temperature with compound 6 in the presence of Li(I) catalyst to avail the targeted library of hybrids ( 8a–q ). All the designed hybrids were screened for their acetylcholinesterase (AChE) and butyrylcholinesterase (BChE), urease, hemolysis and biofilm inhibition potential and were found active with variable potential against all the evaluations. The best compound for AChE inhibition was 8c having 89.24 ± 0.78 % inhibition at 0.5 mM with IC 50 16.43 ± 0.62 μM, while the best against BChE was 8 g with 87.25 ± 0.47 % inhibition and IC 50 31.42 ± 0.34 μM. The whole series of compounds remained potent inhibitors against urease enzyme with better potential as compared to standard thiourea. The potent compounds of the series were 8o and 8i with IC 50 values of 1.32 ± 1.03 μM and 1.38 ± 0.34 μM, respectively. Half of the whole library of compounds ( 8a–q ) possessed outstanding biofilm inhibition potential against the tested bacterial strains and confirmed themselves as better anti-microbial agents. The compounds were also screened for hemolytic activity and results exhibited medium to excellent hemolytic activity. The compound 8b showed the least toxicity among the synthesized compounds, 8a–q . The computational studies of all the synthesized compounds were also carried out to elaborate the binding forces of synthesized compounds with the active sites of enzymes to establish SAR. In silico data supported the in vitro profiles. Further work is suggested for in vivo studies of the most of compounds in search for their anti-cholinesterase and anti-urease potential. Work is in progress on these lines.

Synthesis and examination of 1,2,4‐triazine‐sulfonamide hybrids as potential inhibitory drugs: Inhibition effects on AChE and GST enzymes in silico and in vitro conditions

Pharmacological assessment of disulfide–triazine hybrids: synthesis, enzyme inhibition, and molecular docking study

Synthesis of novel 1,2,3 triazole derivatives and assessment of their potential cholinesterases, glutathione S-transferase enzymes inhibitory properties: An in vitro and in silico study

Assessing the Potential of 1,2,3-Triazole-Dihydropyrimidinone Hybrids Against Cholinesterases: In Silico, In Vitro, and In Vivo Studies

Synthesis, characterization of novel mannich bases and their acetylcholinesterase and glutathione S-transferase inhibitory properties: An in vitro and in silico mechanism research

1,2,4-Triazol 4-Bromobenzenesulfonates: Synthesis, Characterization (IR, NMR), DFT, Enzym Activities, and Docking Study

4‐Furfuryloxymethyl‐1,2,3‐triazol‐1‐yl‐acetohydrazide Hybrids as Cholinesterase and Carbonic Anhydrase Inhibitors: Synthesis, Characterization and Comprehensive Biological Activity Studies

Imidazole‐thiadiazole hybrids: A multitarget de novo drug design approach, in vitro evaluation, ADME/T, and in silico studies

Efficient Access to New Thienobenzo-1,2,3-Triazolium Salts as Preferred Dual Cholinesterase Inhibitors

Synthesis, in silico and in vitro studies of hydrazide‐hydrazone imine derivatives as potential cholinesterase inhibitors

New piperidinyl heterocyclic azoles acquired through Li(I)-catalyzed reactions: Anti-enzymatic, ADME and computational studies

Development of promising acetylcholinesterase and butyrylcholinesterase inhibitors: Synthesis, in vitro and in silico approaches of pyridine derived fused bis-oxadiazole and bis-thiadiazole derivatives

Synthesis of Flavonoid/Sulfonamide Hybrid Molecules as Potential Inhibitors of Cholinesterases: In Vitro, Molecular Docking, Molecular Dynamic and DFT Studies

Synthesis of 1,3‐Disubtitituted Tetrahydropyrimidinium Salts and Determination of Their Biological Properties and Molecular Docking

Exploring Benzo[b][1,4]Thiazine Derivatives: Multitarget Inhibition, Structure–Activity Relationship, Molecular Docking, and ADMET Analysis

New Charged Cholinesterase Inhibitors: Design, Synthesis, and Characterization

Synthesis, in vitro biological evaluation and in silico molecular docking study of hydroxy‐quinoline based sulfonohydrazide derivatives as potential acetylcholinesterase and butyrylcholinesterase inhibitors

Pyrazole-Thiazole Hybrids: Synthesis, Computational Studies and Impact on Digestive Enzymes

Insight from molecular modeling and ADMET analysis: Design, synthesis and in vitro acetylcholinesterase and butyrylcholinesterase assessment of thiazolidinone containing benzoxazole hybrids derivatives

Novel bis-thiazole-thiazolidinone hybrid derivatives: Synthesis, structural properties and anticholinesterase bioactive potential as drug competitor based on docking studies

Synthesis of new N‐(5,6‐methylenedioxybenzothiazole‐2‐yl)‐2‐[(substituted)thio/piperazine]acetamide/propanamide derivatives and evaluation of their AChE, BChE, and BACE‐1 inhibitory activities